ADC Therapeutics presents at Cowen conference; no material updates disclosed

ADC Therapeutics SA

Filed Form 8-K on March 5, 2024, to disseminate a corporate presentation.
Presentation attached as Exhibit 99.1; no financial or pipeline milestones announced.
Available presentation text contains only forward-looking statements and no new data.
No guidance, revenue, or regulatory changes reported in the filing or exhibit snippet.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.